Carlos Custódia

MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma

Pedro M. Costa, Ana L. Cardoso, Carlos Custódia et al. · Journal of Controlled Release · 2015 · 188 citations

Medicine, Oncology, Pharmacology +16

Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model

Joana R. Guedes, Carlos Custódia, Ricardo J. Silva et al. · Human Molecular Genetics · 2014 · 171 citations

Life Sciences, Neurobiology, Neuroscience +17

Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment

Pedro M. Costa, Ana L. Cardoso, Liliana Mendonça et al. · Molecular Therapy — Nucleic Acids · 2013 · 118 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

<i>WNT6</i> is a novel oncogenic prognostic biomarker in human glioblastoma

Céline S. Gonçalves, Joana Vieira de Castro, Marta Pojo et al. · Theranostics · 2018 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +17

Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis

Nan Qin, Eunice Paisana, Maike Langini et al. · Neuro-Oncology · 2022 · 38 citations

Medicine, Cancer Biology, Oncology +17